www.fdanews.com/articles/113978-idri-collaborates-with-brazilian-butantan-institute-to-develop-vaccines
IDRI Collaborates With Brazilian Butantan Institute to Develop Vaccines
January 22, 2009
IDRI (Infectious Disease Research Institute) announced it has granted the Instituto Butantan, a Brazilian biomedical research institution, an exclusive license in Latin America and a non-exclusive license in the rest of the world to use two of IDRI’s lead vaccine antigen candidates for the prevention and treatment of leishmaniasis in humans and dogs.
Yahoo! Finance
Yahoo! Finance